Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.15004 http://scihub22266oqcxt.onion/10.7759/cureus.15004 34150372!8202440!34150372     free     free     free       Cureus 2021 ; 13 (5): e15004 Nephropedia Template TP {{tp|p=34150372|t=2021. Rhabdomyolysis Secondary to COVID-19 Vaccination |pdf=|usr=}}{{34150372}} gab.com Text Rhabdomyolysis Secondary to COVID-19 Vaccination JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34150372 #FOAvip Rhabdomyolysis has been described as a complication of coronavirus disease 2019 (COVID-19) infection, but few cases of rhabdomyolysis associated with COVID-19 vaccination have been reported. We described a case of an 80-year-old male who developed rhabdomyolysis two days after receiving his second dose of the Moderna COVID-19 vaccine. He presented with severe weakness, myalgias, and an initial creatinine kinase (CK) of 6,546 IU/L that improved with intravenous fluids. Common causes of rhabdomyolysis were excluded including statin use, strenuous exercise, and trauma. With the increasing immunization efforts against COVID-19, physicians should consider the possibility of rhabdomyolysis when a patient presents with neuromuscular complaints following vaccination. Twit Text FOAVip Rhabdomyolysis Secondary to COVID-19 Vaccination ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34150372 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34150372 #FOAvip English Wikipedia <ref>{{Cite pmid|34150372}}</ref> Rhabdomyolysis Secondary to COVID-19 Vaccination #MMPMID34150372 Mack M; Nichols L; Guerrero DM Cureus 2021[May]; 13 (5): e15004 PMID34150372show ga Rhabdomyolysis has been described as a complication of coronavirus disease 2019 (COVID-19) infection, but few cases of rhabdomyolysis associated with COVID-19 vaccination have been reported. We described a case of an 80-year-old male who developed rhabdomyolysis two days after receiving his second dose of the Moderna COVID-19 vaccine. He presented with severe weakness, myalgias, and an initial creatinine kinase (CK) of 6,546 IU/L that improved with intravenous fluids. Common causes of rhabdomyolysis were excluded including statin use, strenuous exercise, and trauma. With the increasing immunization efforts against COVID-19, physicians should consider the possibility of rhabdomyolysis when a patient presents with neuromuscular complaints following vaccination. ?Rhabdomyolysis Secondary to COVID-19 Vaccination (epmc).pdf DeepDyve Pubget Overpricing